DK0611373T3 - Oligo-2-desoxynukleotider og deres anvendelse som lægemidler med antiviral virkning. - Google Patents

Oligo-2-desoxynukleotider og deres anvendelse som lægemidler med antiviral virkning.

Info

Publication number
DK0611373T3
DK0611373T3 DK92924466.3T DK92924466T DK0611373T3 DK 0611373 T3 DK0611373 T3 DK 0611373T3 DK 92924466 T DK92924466 T DK 92924466T DK 0611373 T3 DK0611373 T3 DK 0611373T3
Authority
DK
Denmark
Prior art keywords
deoxy
oligodeoxyribonucleotides
desoxynucleotides
oligo
antiviral drugs
Prior art date
Application number
DK92924466.3T
Other languages
English (en)
Inventor
Klaus Muehlegger
Herbert Von Der Eltz
Frank Seela
Helmut Rosemeyer
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Application granted granted Critical
Publication of DK0611373T3 publication Critical patent/DK0611373T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK92924466.3T 1991-05-25 1992-05-25 Oligo-2-desoxynukleotider og deres anvendelse som lægemidler med antiviral virkning. DK0611373T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4117186A DE4117186A1 (de) 1991-05-25 1991-05-25 Oligo-2'-desoxynukleotide und ihre verwendung als arzneimittel mit antiviraler wirksamkeit

Publications (1)

Publication Number Publication Date
DK0611373T3 true DK0611373T3 (da) 1997-10-06

Family

ID=6432469

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92924466.3T DK0611373T3 (da) 1991-05-25 1992-05-25 Oligo-2-desoxynukleotider og deres anvendelse som lægemidler med antiviral virkning.

Country Status (8)

Country Link
EP (1) EP0611373B1 (da)
JP (1) JP2683296B2 (da)
AT (1) ATE150763T1 (da)
CA (1) CA2103062C (da)
DE (2) DE4117186A1 (da)
DK (1) DK0611373T3 (da)
ES (1) ES2102529T3 (da)
WO (1) WO1992021692A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7572582B2 (en) 1997-09-12 2009-08-11 Exiqon A/S Oligonucleotide analogues

Also Published As

Publication number Publication date
CA2103062A1 (en) 1992-11-26
JPH06502655A (ja) 1994-03-24
ES2102529T3 (es) 1997-08-01
JP2683296B2 (ja) 1997-11-26
DE4117186A1 (de) 1992-11-26
CA2103062C (en) 2004-11-30
DE59208280D1 (de) 1997-04-30
EP0611373B1 (de) 1997-03-26
WO1992021692A1 (de) 1992-12-10
ATE150763T1 (de) 1997-04-15
EP0611373A1 (de) 1994-08-24

Similar Documents

Publication Publication Date Title
FI20001231A7 (fi) 2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina
ATE154029T1 (de) 7-deazapurin modifizierte oligonukleotide
DE3854297D1 (de) Nucleoside und nucleotide mit antiviraler, antitumoraler, antimetastatischer sowie immunstimulierender wirkung.
ATE185483T1 (de) Antivirale nucleosidkombination
ATE138384T1 (de) Olionukleotidalkylphosphonate und - phosphonothioate
NO934180L (no) Ryggradmodifiserte oligonukleotidanaloger
ES2171039T3 (es) Producto que comprende al menos un rna bicatenario en asociacion con al menos un interferon para el tratamiento de la hepatitis viral.
NO20035524D0 (no) 4'-substituerte nukleosider
ES2150496T3 (es) Cicloalquilimidazopiridinas condensadas.
ES2161418T3 (es) Compuestos de piridilfurano y de piridiltiofeno y uso farmaceutico de los mismos.
ES2083668T5 (es) Combinaciones antiviricas que contienen analogos de nucleosido.
YU60900A (sh) Novi kristalni oblici antivirusnog benzimidazolskog jedinjenja
DE69323183D1 (de) Weitere indolderivate mit antiviraler wirkung
DK0517986T3 (da) Transformerede erythrocytter, fremgangsmåde til fremstilling af samme og deres anvendelse i farmaceutiske præparater
DK468288D0 (da) Antivirale forbindelser
DK1175489T3 (da) Oligonukleotider indeholdende en antisense-sekvens stabiliseret af en sekundær struktur og farmaceutiske præparater indeholdende disse oligonukleotider
ES2095241T3 (es) Secuencias oligonucleotidicas para la amplificacion del genoma de los retrovirus del tipo hiv-2 y siv, y sus aplicaciones al diagnostico in vitro de las infecciones debidas a estos virus.
ATE294866T1 (de) Zellen, die virus-resistent und von viren infizierbar sind
ES2075835T3 (es) Correccion con arn de doble cadena de una insuficiencia en la arnasa l.
DK0611373T3 (da) Oligo-2-desoxynukleotider og deres anvendelse som lægemidler med antiviral virkning.
DE68900760D1 (de) Virushemmende nukleosidmischung.
DK291390D0 (da) Terapeutiske anvendelser af 2',5'-oligoadenylatderivater
IT1247510B (it) Composizioni terapeutiche ad attivita' anti-hiv costituite da 2',3'-didesossiadenosina e sostanze inibitrici della adenosina-deaminasi
Iordan et al. Effect of vitamin B sub (12) on DNA synthesis of Propionibacterium
SE8802479D0 (sv) Nucleic acid derivatives